We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $999B
1-Year Est. Return 46.22%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
-16.43%
1 Year Est. Return
+46.22%
3 Year Est. Return
+150.45%
5 Year Est. Return
+185.95%
10 Year Est. Return
+1,389.53%
AUM
$791B
AUM Growth
-$200B
Cap. Flow
-$11.4B
Cap. Flow %
-1.44%
Top 10 Hldgs %
26.42%
Holding
3,063
New
88
Increased
1,490
Reduced
1,207
Closed
101

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$3.46B
2
UNH icon
UnitedHealth
UNH
+$2.79B
3
CRM icon
Salesforce
CRM
+$2.38B
4
SHW icon
Sherwin-Williams
SHW
+$1.41B
5
PM icon
Philip Morris
PM
+$1.34B

Sector Composition

Rank Sector Weight
1 Technology 26.68%
2 Healthcare 19.49%
3 Consumer Discretionary 13.07%
4 Financials 11.18%
5 Communication Services 8.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADEA icon
1926
Adeia
ADEA
$3.32B
$923K ﹤0.01%
241,663
-14,360
-6% -$60.2K
AMKR icon
1927
Amkor Technology
AMKR
$14.8B
$923K ﹤0.01%
54,447
+1,263
+2% +$24K
HLNE icon
1928
Hamilton Lane
HLNE
$5.84B
$919K ﹤0.01%
13,674
+811
+6% +$55.9K
NVRI icon
1929
Enviri
NVRI
$580M
$918K ﹤0.01%
129,048
+38,625
+43% +$348K
WKC icon
1930
World Kinect Corp
WKC
$1.89B
$918K ﹤0.01%
44,844
+413
+0.9% +$10.1K
ENS icon
1931
EnerSys
ENS
$7.56B
$914K ﹤0.01%
15,508
+645
+4% +$42.5K
VERU icon
1932
Veru
VERU
$45.5M
$913K ﹤0.01%
8,078
+1,339
+20% +$155K
AEO icon
1933
American Eagle Outfitters
AEO
$2.73B
$911K ﹤0.01%
81,461
+1,061
+1% +$15K
PGNY icon
1934
Progyny
PGNY
$2B
$911K ﹤0.01%
31,351
+4,156
+15% +$149K
TEN
1935
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
$910K ﹤0.01%
53,023
-21,287
-29% -$359K
BEAM icon
1936
Beam Therapeutics
BEAM
$2.68B
$909K ﹤0.01%
23,485
+1,549
+7% +$61.6K
BTU icon
1937
Peabody Energy
BTU
$3.07B
$909K ﹤0.01%
42,632
+3,286
+8% +$80.6K
ATNI icon
1938
ATN International
ATNI
$488M
$908K ﹤0.01%
19,351
+4,739
+32% +$201K
NWBI icon
1939
Northwest Bancshares
NWBI
$2.32B
$908K ﹤0.01%
70,924
+623
+0.9% +$7.94K
MAC icon
1940
Macerich
MAC
$7B
$904K ﹤0.01%
103,838
+810
+0.8% +$9.79K
IPGP icon
1941
IPG Photonics
IPGP
$3.64B
$903K ﹤0.01%
9,595
-41,140
-81% -$4.07M
TDS icon
1942
Telephone and Data Systems
TDS
$4.03B
$903K ﹤0.01%
57,176
-996,432
-95% -$17.8M
AEM icon
1943
Agnico Eagle Mines
AEM
$94.3B
$902K ﹤0.01%
19,749
-55
-0.3% -$3.06K
MTSI icon
1944
MACOM Technology Solutions
MTSI
$23.9B
$902K ﹤0.01%
19,577
+371
+2% +$19.1K
FELE icon
1945
Franklin Electric
FELE
$4.67B
$899K ﹤0.01%
12,270
+506
+4% +$37.5K
ADTN icon
1946
Adtran
ADTN
$682M
$896K ﹤0.01%
51,091
+393
+0.8% +$7.11K
DADA
1947
DELISTED
Dada Nexus
DADA
$895K ﹤0.01%
110,376
-27,650
-20% -$212K
COOP
1948
DELISTED
Mr. Cooper
COOP
$890K ﹤0.01%
24,211
+1,360
+6% +$57.6K
ACI icon
1949
Albertsons Companies
ACI
$6.01B
$884K ﹤0.01%
33,096
+11,567
+54% +$354K
SKT icon
1950
Tanger
SKT
$4.44B
$882K ﹤0.01%
62,006
+505
+0.8% +$8.38K

Similar funds

T. Rowe Price Associates's Q2 2022 Portfolio in Review

As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
  • T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
  • T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
  • T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
  • T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
  • T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
  • T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.

Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.